Ownership history in CM Management, LLC · 11 quarters on record
This page tracks every 13F SEC filing in which CM Management, LLC reported a position in ELICIO THERAPEUTICS INC (ELTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 25,000 | +19,000 | +316.7% | 0.17% | $199K | $7.96 |
| 2025 Q3 | REDUCED | 6,000 | -19,000 | -76.0% | 0.05% | $66K | $10.94 |
| 2025 Q2 | REDUCED | 25,000 | -30,000 | -54.5% | 0.18% | $193K | $7.72 |
| 2025 Q1 | ADDED | 55,000 | +15,000 | +37.5% | 0.34% | $339K | $6.16 |
| 2024 Q4 | REDUCED | 40,000 | -10,000 | -20.0% | 0.18% | $204K | $5.10 |
| 2024 Q3 | UNCHANGED | 50,000 | — | 0% | 0.20% | $252K | $5.03 |
| 2024 Q2 | REDUCED | 50,000 | -25,000 | -33.3% | 0.19% | $206K | $4.11 |
| 2024 Q1 | ADDED | 75,000 | +25,000 | +50.0% | 0.48% | $570K | $7.60 |
| 2023 Q4 | REDUCED | 50,000 | -15,000 | -23.1% | 0.34% | $417K | $8.34 |
| 2023 Q3 | UNCHANGED | 65,000 | — | 0% | 0.58% | $549K | $8.45 |
As of 2025 Q4 — sorted by position size